Financhill
Back

Bristol Myers Squibb Co. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
73

BMY
Bristol Myers Squibb Co.

Last Price:
$55.91
Seasonality Move:
12.83%
Sell
38

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.22
Seasonality Move:
-13.28%
Buy
73
Bristol Myers Squibb Co. (BMY) is a Buy

Is Bristol Myers Squibb Co. a Buy, Sell or Hold?

  • The current Bristol Myers Squibb Co. [BMY] share price is $56.72. The Score for BMY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • BMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.34. The Score for CRNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMY Stock Price Chart

What is Bristol Myers Squibb Co.'s stock price today?

  • The Bristol Myers Squibb Co. share price today is $56.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.37 Buy
Relative Strength Index (14 RSI): 71.58 Buy
Chaikin Money Flow: 17563664 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.38 - 54.88) Buy
Bollinger Bands (100): (44.34 - 51.38) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.96 Buy
Relative Strength Index (14 RSI): 66.03 Buy
Chaikin Money Flow: 3428689 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.13 - 49.63) Buy
Bollinger Bands (100): (35.09 - 47.19) Buy

BMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.32 Buy
20-day SMA: 53.66 Buy
50-day SMA: 49.94 Buy
200-day SMA: 48.44 Buy
8-day EMA: 54.52 Buy
20-day EMA: 53.41 Buy
50-day EMA: 50.92 Buy
200-day EMA: 49.38 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.2 Buy
20-day SMA: 48.28 Buy
50-day SMA: 45.42 Buy
200-day SMA: 36 Buy
8-day EMA: 48.68 Buy
20-day EMA: 47.84 Buy
50-day EMA: 45.56 Buy
200-day EMA: 40.15 Buy

Bristol Myers Squibb Co. Earnings Growth & BMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.16 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.55 per share.

Bristol Myers Squibb Co. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):